Literature DB >> 10822347

Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence.

C Lerman1, N E Caporaso, J Audrain, D Main, N R Boyd, P G Shields.   

Abstract

Individual differences in propensity to nicotine dependence appear to be mediated, in part, by genetic factors.1 The serotonin transporter gene has a functional polymorphism (5-HTTLPR) which modulates gene transcription and reuptake.2,3 A possible role in nicotine dependence is suggested by a link between 5-HTTLPR and neuroticism,4 a personality trait which has been related to smoking practices.5 In a cross-sectional study of 185 smokers, we utilized multiple linear regression modeling to examine the interacting effects of the 5-HTTLPR and neuroticism on smoking practices and nicotine dependence. Genotype was classified according to the presence or absence of the short (s) allele vs the long (l) allele of 5-HTTLPR (ie, s/s or s/l vs l/l). Models controlled for gender, age, race, and alcohol use. The 5-HTTLPR by neuroticism interaction effect was statistically significant in the models of nicotine intake (P = 0.05), nicotine dependence (P = 0.001), and smoking motivations (smoking to reduce negative mood (P = 0.01); smoking for stimulation (P = 0.01)). The results suggested that neuroticism was positively associated with these smoking practices among smokers with 5-HTTLPR S genotypes (s/s or s/l), but not among smokers with the L genotype (l/l). The 5-HTTLPR may modify the effects of neuroticism on smoking motivations and nicotine dependence. Assessment of 5-HTTLPR genotype and neuroticism may help to identify smokers who are more responsive to psychotropic medications, such as selective serotonin reuptake inhibitors (SSRIs), which are being used in smoking cessation treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822347     DOI: 10.1038/sj.mp.4000672

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  32 in total

Review 1.  Genetics of smoking and depression.

Authors:  Ming T Tsuang; Tracee Francis; Kyle Minor; Alison Thomas; William S Stone
Journal:  Hum Genet       Date:  2012-04-17       Impact factor: 4.132

2.  Personality and Substance Use in Midlife: Conscientiousness as a Moderator and the Effects of Trait Change.

Authors:  Nicholas A Turiano; Shawn D Whiteman; Sarah E Hampson; Brent W Roberts; Daniel K Mroczek
Journal:  J Res Pers       Date:  2012-06-01

3.  The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial.

Authors:  Sean P David; Marcus R Munafò; Michael F G Murphy; Robert T Walton; Elaine C Johnstone
Journal:  Nicotine Tob Res       Date:  2007-02       Impact factor: 4.244

Review 4.  Genetics and smoking behavior.

Authors:  Robert A Schnoll; Terrance A Johnson; Caryn Lerman
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

5.  Smoking cessation in patients with psychiatric disorders.

Authors:  Alan J Gelenberg; Jose de Leon; A Eden Evins; Joseph J Parks; Nancy A Rigotti
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

6.  5-HTTLPR genotype and anxiety-related personality traits: a meta-analysis and new data.

Authors:  Marcus R Munafò; Nelson B Freimer; Whitney Ng; Roel Ophoff; Juha Veijola; Jouko Miettunen; Marjo-Riitta Järvelin; Anja Taanila; Jonathan Flint
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-03-05       Impact factor: 3.568

7.  Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.

Authors:  Sean P David; Elaine C Johnstone; Michael F G Murphy; Paul Aveyard; Boliang Guo; Caryn Lerman; Marcus R Munafò
Journal:  Drug Alcohol Depend       Date:  2008-06-17       Impact factor: 4.492

Review 8.  Genetic polymorphism of serotonin transporter 5-HTTLPR: involvement in smoking behaviour.

Authors:  Maria Angelica Ehara Watanabe; Sandra Odebrecht Vargas Nunes; Sandra Odebrechet Vargas Nunes; Marla Karine Amarante; Roberta Losi Guembarovski; Julie Massayo Maeda Oda; Kalil William Alves De Lima; Maria Helena Pelegrinelli Fungaro
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

9.  A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans.

Authors:  Sean P David; Naga Venkatesha Murthy; Eugenii A Rabiner; Marcus R Munafó; Elaine C Johnstone; Robyn Jacob; Robert T Walton; Paul M Grasby
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

10.  Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood.

Authors:  Kenneth A Perkins; Caryn Lerman; Amy Grottenthaler; Melinda M Ciccocioppo; Melissa Milanak; Cynthia A Conklin; Andrew W Bergen; Neal L Benowitz
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.